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Abstract
After 20 years with no reported measles cases, on May 15, 2014 the Centers for Disease Control 
and Prevention (CDC) was notified of two cases testing positive for measles-specific 
immunoglobulin M (IgM) antibodies in the Federated States of Micronesia (FSM). Under the 
Compact of Free Association, FSM receives immunization funding and technical support from the 
United States (US) domestic vaccination program managed by the Centers for Disease Control and 
Prevention (CDC). In a collaborative effort, public health officials and volunteers from FSM and 
the US government worked to respond and contain the measles outbreak through an emergency 
mass vaccination campaign, contact tracing, and other outbreak investigation activities. 
Contributions were also made by United Nations Children’s Emergency Fund (UNICEF) and 
World Health Organization (WHO). Total costs incurred as a result of the outbreak were nearly 
$4,000,000; approximately $10,000 per case. Direct medical costs (≈$141,000) were incurred in 
the treatment of those individuals infected, as well as lost productivity of the infected and informal 
caregivers (≈$250,000) and costs to contain the outbreak (≈$3.5 million). We assessed the 
economic burden of the 2014 measles outbreak to FSM, as well as the economic responsibilities of 
the US. Although the US paid the majority of total costs of the outbreak (≈67%), examining each 
country’s costs relative to their respective economy illustrates a far greater burden to FSM. We 
demonstrate that while FSM was heavily assisted by the US in responding to the 2014 Measles 
Outbreak, the outbreak significantly impacted their economy. FSM’s economic burden from the 
outbreak is approximately equivalent to their entire 2016 Fiscal Year budget dedicated to 
education.
*Corresponding author at: Immunization Services Division, National Center for Immunization and Respiratory Disease, Centers for 
Disease Prevention and Control, 1600 Clifton Road NE, MS A-19, Atlanta, GA 30329-4027, United States. jpike@cdc.gov (J. Pike). 
Conflict of interest
All authors have read and approved the manuscript, and there are no financial disclosures, conflicts of interests and/or 
acknowledgements necessary.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers 
for Disease Control and Prevention.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.vaccine.2017.08.075.
HHS Public Access
Author manuscript
Vaccine. Author manuscript; available in PMC 2018 March 01.
Published in final edited form as:
Vaccine. 2017 October 13; 35(43): 5905–5911. doi:10.1016/j.vaccine.2017.08.075.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Cost of outbreak; Economic burden; Federated States of Micronesia; Measles
1. Introduction
Measles is a highly contagious rash illness that is transmitted from person to person by 
direct contact with respiratory droplets or airborne spread [1]. Once a common disease, 
tremendous progress has been made to reduce measles burden across the world, and cases 
have dramatically decreased with proliferation of two dose measles-containing vaccine 
coverage use [2]. According to the World Health Organization (WHO), from 2000 to 2014, 
measles mortality decreased by 79% from an estimated 546,800 in 2000 to 114,900 in 2014, 
and vaccination prevented an estimated 17.1 million deaths [3]. As a result, the WHO Global 
Vaccine Action Plan for 2012–2020 aims to eliminate measles in at least five WHO Regions 
by 2020 [2]. Despite the availability of a safe and effective vaccine, measles remains one of 
the leading causes of death among young children [3].
As a member country of the WHO Western Pacific Region, the Federated States of 
Micronesia (FSM) is committed to eliminating measles through achieving and maintaining 
regional goals of ≥95% vaccination coverage with 2 doses of measles-containing vaccine 
(MCV) for each birth cohort of children (WHO website).1 Under the Compact of Free 
Association, FSM receives immunization funding and technical support from the United 
States (US) domestic vaccination program managed by the Centers for Disease Control and 
Prevention (CDC). The international agreement establishes and governs the relationships of 
free association between the US and the three Pacific Island nations that formerly comprised 
the Trust Territory of the Pacific Islands: the Federated States of Micronesia, the Marshall 
Islands, and Palau [4]. Measles vaccination policy has evolved in FSM from one dose of 
monovalent measles vaccine at 9 months of age in 1963, to the current recommendation of 
two doses of measles, mumps, and rubella (MMR) vaccine, administered at 12 and ≥13 
months [5,6]. Two doses of MMR are required for school entry [5,6], although enforcement 
is not stringent.
After 20 years with no reported measles cases, on May 15, 2014, CDC was notified of two 
cases testing positive for measles-specific immunoglobulin M (IgM) antibodies in FSM. 
Subsequently, 393 cases of measles were confirmed in FSM; 140 (36%) were laboratory 
confirmed, 244 (62%) were epidemiologically confirmed, and nine (2%) were clinically 
compatible [5,7].
In a collaborative effort, FSM public health officials, volunteers supplied by FSM, and staff 
from CDC worked to respond and contain the measles outbreak through an emergency mass 
vaccination campaign, contact tracing, and other outbreak investigation activities. 
Contributions were also made by United Nations Children’s Emergency Fund (UNICEF) 
and WHO. Direct medical costs were incurred in the treatment of those individuals infected, 
1A single dose of MCV was introduced in FSM in 1963 and was replaced in 1982 with the MMR vaccine. A second dose of MMR 
was introduced was introduced in 1995.
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as well as costs from lost productivity of the infected and time of the care-givers, and costs 
to contain the outbreak.
During a measles outbreak, the resources needed to identify and treat contacts can strain 
local public health resources [8]. In the case of FSM, a lower middle income country with a 
narrowly-based economy, this strain on resources was exacerbated by the unique logistical, 
economic, and geographical challenges in confirming diagnosis and containing the outbreak 
in a vast archipelago of islands with small and dispersed human populations. Although many 
aspects of this study are relevant to other countries, the idiosyncrasies of this event coupled 
with the Compact of Free Association with the US provide an opportunity to determine the 
economic implications of such an event to all parties. The objective of this report is to assess 
the economic burden of the 2014 measles outbreak to FSM in terms of containment costs, 
direct medical costs, and productivity losses, as well as the economic responsibilities of the 
US. Although the US paid the majority of total costs of the outbreak, examining each 
country’s costs relative to their respective economy illustrates a far greater burden to FSM.
2. Methods
2.1. Setting
FSM is an independent nation comprising 607 islands located just north of the Equator in the 
Western Pacific Ocean. The islands are dispersed across 1 million square miles (2.6 million 
square kilometers) of ocean. FSM is made up of four groups of island states in geographic 
sequence from west to east: Yap, Chuuk, Pohnpei and Kosrae. According to the 2010 census, 
the population of 102,843 is distributed as follows: Chuuk (48,654 residents), Pohnpei 
(36,196), Yap (11,377), and Kosrae (6616) [5,7,9].
2.2. Outbreak
FSM was assisted by CDC in investigating suspected cases, identifying contacts, conducting 
analyses to guide outbreak vaccination response, and reviewing vaccine cold chain practices. 
Complementary funds to assist in the outbreak response were provided by CDC, WHO, and 
UNICEF. From February 16, 2014 through August 2014, three of FSM’s four states reported 
measles cases: Kosrae (139 cases), Pohnpei (251), and Chuuk (3). In Kosrae and on the 
mainland of Pohnpei, cases were reported in all municipalities; in Chuuk only one 
municipality (out of 40) reported cases. Although 16 suspected cases were investigated in 
Yap, these cases were ruled out following negative laboratory results. Cases were identified 
by febrile rash illness surveillance at the hospital, contact tracing, and a retrospective 
investigation of earlier fever and rash cases [7,10].
Median age of cases was 24 years, with 250 (64%) cases aged >19 years. Among adult cases 
aged ≥20 years, 49% had received ≥2 doses of measles-containing vaccine. Measles 
incidence was lower among children than adults, except infants <12 months who were too 
young for vaccination. Attack rates were highest for infants (22 cases per 1000 population), 
followed by adults aged 20–29 years (seven per 1000), and 30–39 years (six per 1000) [7].
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2.3. Cost analysis
We defined the analysis period as May 1, 2014, two weeks prior to the first case of measles 
was reported to the CDC to encompass the incubation period, through December 10, 2014, 
when the vaccination campaign was completed [1,7,11]. This analysis uses standard cost 
analysis methods [12]. Costs of the 2014 outbreak were retrospectively collected and 
categorized into three main categories: (1) outbreak containment costs, (2) direct medical 
and non-medical costs, and (3) productivity losses (Fig. 1). Costs were collected from the 
FSM Department of Health, CDC, the FSM Office of Statistics, Budget and Economic 
Management, Overseas Development Assistance and Compact Management (SBOC), 
UNICEF, WHO, Feds Data Center, the International Monetary Fund (IMF), and the World 
Bank (Appendix 1, Table 1).[9,13-20] All expenses are in 2014 US dollars [21].
2.4. Containment
Containment activities were comprised of both an outbreak investigation and a mass 
vaccination campaign. Outbreak investigation efforts included contact tracing, conducting a 
retrospective review of prior fever and rash cases, conducting vaccination record checks, and 
assessing vaccine storage and handling practices. Further, samples had to be shipped and 
reshipped to different labs in either Guam, Hawaii, or Atlanta. This required significant 
person hours spent getting these samples to and from the airports and repackaging them for 
shipment.
To interrupt transmission and contain the outbreak, the mass vaccination campaign was 
launched successively in each FSM state pursuing children as young as age 6 months 
through adults up to age 57 years. In Kosrae, the campaign included vaccination record 
checks and only persons who did not have two documented doses of MCV were vaccinated. 
Campaigns in Pohnpei and Chuuk targeted all persons 6 months through 49 years of age, 
without checking vaccination status. In Yap, persons age 19–49 years were vaccinated 
without checking vaccination records, but those age 1–18 were vaccinated only if they did 
not have two documented doses of MCV [7]. The campaign targeted 82,472 individuals—
80% of the national population. Because FSM includes 607 dispersed islands spanning 1700 
miles, numerous boats were necessary as the primary mode of transportation for the 
outreach vaccination teams. When boats could not reach the shore during low tides, 
immunization staff had to carry the campaign supplies over the reef. Further, fixed and 
outreach vaccination posts were set up, as well as mobile vaccination units and door-to-door 
efforts, which were utilized to immunize hard-to-reach populations, such as isolated 
communities inhabiting mountainous terrain [10].
During the outbreak, eleven CDC employees were deployed to FSM, with one individual 
traveling twice to FSM. Non-deployed CDC staff worked over two-thousand hours, 
primarily conducting laboratory specimen testing. Approximately 32 individuals in Pohnpei, 
44 in Chuuk, 20 in Kosrae, and 16 in Yap, composed of nurses, health assistants, data 
assistants, and health educators, participated in the vaccination campaign spanning nearly 5 
months. Nine individuals from FSM participated in the vaccine coverage assessment.
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Aside from boat rentals, other transportation costs included car rentals, airfare, fuel, 
departure fees, and shipping of vaccines and supplies. A total of 79,150 doses of vaccine 
were purchased by the US; 55,9602 pediatric doses and 23,550 adult doses. UNICEF also 
supplied 10,000 additional doses of MR vaccine (for ages 25 yrs – 49 yrs) and 2620 MR 
doses on hand were used. A public awareness campaign was implemented, including radio 
announcements and posters.
2.5. Direct costs
Direct medical costs can be defined as those costs incurred to secure medical treatment, such 
as hospitalization. Direct nonmedical costs are direct costs incurred in connection with a 
health outcome, such as shipment of specimens for testing. For this study, direct medical 
costs included hospitalization and non-hospitalization treatment and medication costs. Direct 
non-medical costs included laboratory specimen testing, supplies, shipping, and labor. Due 
to limited capacity to perform diagnostic tests for measles, samples were sent to laboratories 
in Atlanta, Guam and Hawaii for confirmation. Consequently, lab shipment costs were 
incurred, in addition to labor and materials. Hospitalization and non-hospitalization costs 
included treatment, evaluation, case management, medications, and hospital bed occupation 
fees.
2.6. Productivity losses
Productivity losses are costs foregone due to disability or death resulting from a health 
problem, such as absenteeism, job loss, or reduced productivity while at work 
(presenteeism). These costs are essentially the value of resources lost to society due to an ill 
employee. They also may include resources lost to society due to an employee caring for an 
ill person, such as a parent missing work to care for a sick child. Typically, productivity 
losses due to illness or injury include gross earnings calculated using the human capital 
approach, including payroll taxes and employer paid benefits to capture the full cost of 
employee compensation. Imputed household earnings are also generally included as part of 
productivity losses.
To value lost productivity due to death, we apply the value of statistical life (VSL); the 
amount of money a society is willing to spend to save a life. According to a study by 
Hammit and Robinson (2011), U.S. regulatory agencies have well-established approaches 
for estimating the base VSL [22]. Further, international studies have relied on this same 
research for their base estimates. These base estimates are derived largely from wage-risk 
studies conducted in the U.S. and other high income countries. We apply the U.S. 
Department of Transportation’s (DOT’s) estimate of $9.1 million (2014$) [23], which relies 
on one wage-risk study [24] and four meta-analyses [25-28]. VSL represents individuals’ 
willingness to exchange income for small changes in mortality risks. Therefore, VSL should 
increase as income increases, but the increase may not be proportional [22]. Therefore, 
following Hammitt and Robinson (2011)), a sensitivity analysis is applied to the income 
2Vaccine funding via the CDC is awarded directly to contracts with vaccine manufacturers. FSM ordered the vaccines via the CDC 
online ordering system (VTrckS). The centralized distributor fills, packs, and ships the order. FSM might have ordered vaccines at a 
cheaper price through UNICEF using local funds, but timing of procurement may have factored into the decision process. A CDC 
contracted distributor will deliver within a week of placing the order, whereas ordering through UNICEF can take up to two months.
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elasticity when transferring values from the US to FSM [22]. We apply elasticities of 1.0, 
1.5, and 2.0. The VSL estimate should be bounded below by estimates of future income or 
consumption. Due to lack of data on consumption, we bound below only by future income.
3. Results
Total costs incurred as a result of the 2014 Measles Outbreak were nearly $4,000,000. 
Although vaccines were the largest driver of costs for the total outbreak, FSM labor costs 
dominated their economic burden of the outbreak (Table 2, Fig. 2).
Labor costs, for both the outbreak investigation and vaccination campaign, incurred by the 
US totaled approximately $80,000. For FSM, these labor costs were over $300,000. The 
bulk of containment costs were the vaccine purchase by the US, totaling nearly $2 million. 
UNICEF also provided 10,000 adult doses of vaccines (Table 1). FSM incurred car and boat 
rental and fuel charges as part of the outreach vaccination, as well as travel costs between 
states, contributing a total of $94,000 to FSM’s containment expenses. WHO contributed 
$80,000 toward logistical costs of the vaccination campaign. In total, $3.5 million was 
incurred in containment expenses by FSM, the US, UNICEF, and WHO (Table 2).
A total of $141,000 in direct medical and nonmedical costs were incurred during the 
outbreak (Table 2). Laboratory testing labor, materials, and shipping were incurred by the 
US, totaling nearly $99,000. Hospitalization and non-hospitalizations costs were incurred by 
FSM, totaling almost $42,000.
Productivity losses included the value of resources lost to society due to death or illness. For 
losses due to illness, an average daily wage of $31.65 is applied. Two–thirds of the 
diagnosed cases were identified as adults of working age. For the remaining adolescent and 
infant cases, we assume informal caretaker time was incurred by at least one parent. An 
average daily wage of $31.65 is applied to the caregiver time. Of the 393 diagnosed cases, 
124 cases were hospitalized. Assuming the more severe cases (inpatient) will not be able to 
work for 15 working days (or a parent is caring for an adolescent or infant) results in lost 
productivity costs of approximately $59,000. Assuming a more conservative period of five 
lost working days (by the patient or caregiver) for outpatient cases (n = 269) results in lost 
productivity costs of approximately $42,500 (Table 2).
One infant (21 months old) fatality from measles occurred in the state of Pohnpei. The result 
(Table 3) is a lost productivity estimate ranging from $2.3 million to $37,000, an average of 
$584,000. Conservatively, we estimated lost productivity due to death as $148,000 (income 
elasticity = 1.5).
4. Discussion
Total costs incurred as a result of the 2014 Measles Outbreak were nearly $4,000,000; 
approximately $10,000 per case. These costs were incurred by agencies within FSM, CDC, 
WHO, and UNI-CEF. Not surprisingly, vaccines dominating the cost for the total outbreak 
(Table 2). Further, 99% of FSM labor costs were incurred in the vaccination outreach. A 
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vaccination campaign often comprises a significant portion of the total costs incurred in 
responding to vaccine-preventable disease outbreaks [29].
Containment costs (outbreak response and vaccination campaign) comprised 90% of the 
costs of the outbreak. Many of these costs were attributed to the geographic constraints of 
the region, but pale in comparison to the cost of the vaccines. The US paid for 66% of the 
containment costs (85% of the vaccine purchases), while FSM paid 22%, and together 
UNICEF and WHO paid 11% (Table 2).
Direct costs totaled approximately $140,000 with 70% paid for by CDC in laboratory testing 
materials and labor. The remaining 30% were inpatient and outpatient costs incurred by 
FSM. All productivity losses were incurred by FSM, totaling nearly $250,000 (6% of total 
costs).
Of the total cost of the outbreak (nearly $4 million), FSM paid 22% (approximately 
$847,742). To illustrate this impact from FSM’s perspective, FSM’s total cost of the 
outbreak is approximately equivalent to FSM’s Fiscal Year 2016 Department of Education 
budget ($849, 723) [30].
The US paid 67% of the total outbreak costs and together UNICEF and WHO paid 11%. 
Although the US paid the majority of the costs, these costs must be put into perspective 
relative to the US and FSMs respective economies. The US 2014 gross national income 
(GNI) (PPP)3 was $17.8 trillion, while FSMs GNI (PPP) was $373 million. Considering the 
expenses incurred in proportion to each county’s GNI, the US paid 0.00001% and FSM paid 
0.23% (Table 4).
5. Limitations
While examining the results of this study, there are several limitations that should be taken 
into consideration. First, due to lack of data, many costs were excluded. For example, time 
lost and travel costs of the patients seeking healthcare are not included in our analysis. 
Second, in the productivity cost component of the cost of outbreak, payroll taxes and 
employer paid benefits are not included in gross earnings, nor are imputed household 
earnings. Both of these limitations likely underestimate the true costs of the outbreak. Third, 
we used many proxies for true costs or donations. For example, for the majority of supplies 
utilized in the mass vaccination campaign, costs were extracted from the published UNICEF 
price lists; there is no consideration of price markup. Also, wages are the averages for the 
country; we did not have access to patient level wage data. Lastly, we do not consider costs 
incurred to the US from the 59 imported cases. Chen et al. (2011) studied the importation 
response costs of a predominantly health care–associated measles outbreak involving 14 
cases [31]. They estimated that two hospitals spent US$799,136 responding to and 
containing 7 cases in their facilities; representing a mean cost of $105,347 per case at 
3Purchasing power parity (PPP) conversion factors take into account differences in the relative prices of goods and services—
particularly non-tradables—and therefore provide a better overall measure of the real value of output produced by an economy 
compared to other economies. PPP GNI is measured in current international dollars which, in principal, have the same purchasing 
power as a dollar spent on GNI in the U. S. economy. (World Bank).
Pike et al. Page 7
Vaccine. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
hospital A and $167,052 for 1 case at hospital B. Averaging these costs across the 14 cases 
results in approximately $57,000 per case. Using this estimate would add over $3 million to 
the cost of the FSM measles outbreak.
6. Implications
FSM is a lower-middle income country with an economy more susceptible to the negative 
consequences of harmful events such as the 2014 measles outbreak. According to the World 
Bank, because FSM is a narrowly-based economy with large distances to major markets, the 
country is vulnerable to exogenous shocks, which can affect growth and often lead to a high 
degree of economic volatility [20]. During 2010 and 2011, WHO supported FSM in 
performing a climate change and health vulnerability and adaptation assessment. Infectious 
diseases were among the highest priority climate-sensitive health risks identified in FSM 
[32]. We demonstrate that although FSM was heavily assisted by the US in responding to the 
2014 measles outbreak, the outbreak significantly affected their economy.
In the case of the 2014 FSM measles outbreak, vaccine failure among previously immunized 
individuals appeared to facilitate transmission. Failure of vaccine effectiveness has been 
identified as a source of the outbreak [5,7]. In response to the outbreak, Hales et al. (2016) 
studied low vaccine effectiveness in adults in the state of Pohnpei finding vaccine 
suboptimal storage and handling of MCV may have caused the low vaccine effectiveness 
[5]. CDC provides recommendations on storage and handling of vaccines; vaccines must be 
stored properly from the time they are manufactured until they are administered, which is a 
shared responsibility among manufacturers, distributors, public health staff, and healthcare 
providers [33,34]. CDC is working with FSM to expand, develop, and strengthen vaccine 
management. In addition, outbreaks of measles often occur in communities with low 
vaccination coverage, where many individuals have not received the vaccine [7,35-37]. It is 
critical to ensure vaccination coverage is kept at optimal levels. School requirements have 
been linked to increased vaccination coverage [38,39]. Under Code of the Federated States 
of Micronesia Title 41, Chapter 4, “no child shall attend any school within the Federated 
States of Micronesia unless such child shall have presented to an appropriate official of the 
school, a certificate of immunization against such communicable diseases as may be 
specified by the Department of Social Services in accordance with the provisions of section 
405 of this chapter.” The emergency mass vaccination campaign conducted during the 
outbreak assisted with providing protection to the people of FSM; strengthening 
enforcement of school vaccination requirements will help maintain high vaccination 
coverage.
The economic burden of the vaccine failure and ultimately, the outbreak, to FSM coupled 
with the unique relationship between FSM and the US underscores the need for further 
research on the cost-effectiveness of interventions that could have prevented the outbreak, 
such as conducting serosurveys and improving vaccine management. We propose further 
research to identify (1) the additional consequences of controlling the outbreak to a unique, 
island economy (i.e. long-term macro effects, imported cases to the US) and (2) the value of 
avoiding these consequences through varying levels of intervention (i.e. quarantine, various 
targets of vaccination).
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Costs of the 2014 Federated States of Micronesia Measles outbreak retrospectively collected 
and categorized into three main categories: (1) outbreak containment costs, (2) direct 
medical and non-medical costs, and (3) productivity losses. Costs were collected from the 
FSM Department of Health, the CDC, the FSM Office of Statistics, Budget and Economic 
Management, Overseas Development Assistance and Compact Management (SBOC), 
UNICEF, WHO, Feds Data Center, the International Monetary Fund (IMF), and the World 
Bank [9,13-20].
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Fig. 2. 
Labor, vaccines, materials, and logistics costs related to the containment of the 2014 
Federated States of Micronesia Measles outbreak retrospectively collected. Costs were 
collected from the FSM Department of Health, the CDC, the FSM Office of Statistics, 
Budget and Economic Management, Overseas Development Assistance and Compact 
Management (SBOC), UNICEF, WHO, Feds Data Center, the International Monetary Fund 
(IMF), and the World Bank [9,13-20].
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Table 4
Estimated cost of the 2014 FSM measles outbreak to FSM and the US relative to each respective economy 
(2014$).
Cost of Outbreak (COO) GNI PPP COO relative to country economy
FSM $847,742 $373,216,892 0.22714%
US $2,656,835 $17,823,200,000,000 0.00001%
Estimated total costs of the 2014 Federated States of Micronesia Measles outbreak paid by the Federated States of Micronesia and the United 
States, the United States 2014 gross national income (GNI) (PPP), the Federated States of Micronesia GNI (PPP) and costs incurred in proportion 
to each county’s GNI.
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